New enzymes and mixing technology can more than double production capacity

In March, Hofseth BioCare conducted a full-scale test production with new proprietary enzymes at our plant in Midsund. The analyzes from the batches have now confirmed the positive results of lab tests in Germany in the fall.

New enzymes and new mixing technology will result in significant capacity increases and cost reductions for Hofseth BioCare in the future. Mixing technology has not yet been installed at the factory in Midsund, but this is an investment management will prioritize over the next six months. Hofseth BioCare can reduce the hydrolysis time compared with the current production and allows us to produce 50,000 tons of fish trimmings per year, compared to current capacity of 20,000 tons.